December 12, 2013 7:29 AM | 30 seconds read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Analysts at Credit Suisse downgraded Infinity Pharmaceuticals (NASDAQ: INFI) from “outperform” to “neutral.” The target price for Infinity Pharmaceuticals is set to $20. Infinity's shares closed at $13.31 yesterday. Analysts at JMP Securities downgraded Progress Software (NASDAQ: PRGS) from “market outperform” to “market perform.” Progress Software's shares closed at $25.60 yesterday.RBC Capital downgraded Oracle (NASDAQ: ORCL) from “outperform” to “sector perform.” The target price for Oracle is set to $35. Oracle's shares closed at $34.56 yesterday. William Blair downgraded Brown & Brown (NYSE: BRO) from “market perform” to “underperform.” Brown & Brown's shares closed at $30.26 yesterday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.